Autologous Intravitreal Bone-marrow CD34+ Stem Cells

CD34+ stem cells from autologous bone marrow · University of California, Davis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous Intravitreal Bone-marrow CD34+ Stem Cells, covering 2026-01-29 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy [Phase 1]

See pricing